HB228 - Permit an opioid treatment program to be developed if part of a clinical trial, approved by an institutional review board

2 Co-Sponsors

The purpose of this bill is to permit an opioid treatment program to be developed if part of a clinical trial, approved by an institutional review board. The bill sets forth the opioid treatment program services to be developed and provides for a set timeframe. The opioid treatment program is required to register with the Board of Pharmacy. The bill permits an advanced practice registered nurse participating in a clinical trial, approved by an institutional review board, to dispense medication for the timeframe approved in the clinical trial after registering with the Board of Pharmacy. The bill permits the advanced practice registered nurse participating in a clinical trial, approved by an institutional review board, to exceed a 3-day supply for the timeframe of the clinical trial, after registering with the Board of Medicine.